Skip to content

ENDOCYTE INC

CIK 0001235007

← back to feed
Revenue (TTM)
$75.32K
−63.6% YoY Q3 Oct 2018
Net Income (TTM)
−$56.04M
+63.2% YoY Q3 Oct 2018
EPS Diluted (TTM)
−$0.11
−6.1% YoY Q3 Oct 2018
Gross Margin
—
Q3 Oct 2018
Operating Margin
-77,508.4%
Q3 Oct 2018
Net Margin
-74,404.7%
Q3 Oct 2018
Free Cash Flow (TTM)
−$43.63M
Q3 Oct 2018
Cash
$67.27M
Q3 Oct 2018
Total Debt
$0
Q3 Oct 2018
Shares Outstanding
82.09M sh
Q3 Oct 2018

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings